Daniel N. Silverman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daniel N. Silverman has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Margaret Infeld
Tufts Medical Center
5 shared publications - Markus Meyer
Lillehei Heart Institute, Department of Medicine, University of Minnesota College of Medicine, Minneapolis (M.M.).
5 shared publications - Brian A. Houston
Division of Cardiology, Medical University of South Carolina, Charleston, South Carolina
3 shared publications - Rachel Biggs
Medical University of South Carolina, Department of Medicine, Division of Cardiology, Medical University of South Carolina, Charleston, SC
3 shared publications - Ryan J. Tedford
Division of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, SC (R.J.T.).
3 shared publications Ahmed A. Ismail
Medical University of South Carolina, Department of Medicine, Division of Cardiology, Medical University of South Carolina, Charleston, SC
2 shared publications
Latest Publications
- Open Access
- 27 December 2025
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 45 (10) , 1658-1671
Mechanical stretch reduces fibroblast activation in heart failure with reduced ejection fraction
- 27 December 2025
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 45 (10) , 1658-1671
Open AccessMechanical stretch reduces fibroblast activation in heart failure with reduced ejection fraction
- 11 November 2025
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 31 (11) , 1695-1697
The Dog Wagging the Tail Wagging the Dog: Pacemakers as a Surrogate (and Treatment?) for More Extensive Negative Cardiac Remodeling in HFpEF
- 11 November 2025
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 31 (11) , 1695-1697
The Dog Wagging the Tail Wagging the Dog: Pacemakers as a Surrogate (and Treatment?) for More Extensive Negative Cardiac Remodeling in HFpEF
- Open Access
- 15 April 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (8) , e039747
Persistent Fibrosis in Heart Failure With a Reduced Ejection Fraction Linked to Phenotypic Differences in Human Cardiac Fibroblast Populations
Background: Myocardial fibrosis is prevalent in cardiomyopathies that result in heart failure with reduced ejection fraction. Heart failure with reduced ejection fraction treated with a left ventricular assist device (LVAD) yields hemodynamic unloading and may provide partial cardiomyocyte recovery, but contemporary studies reveal no consistent reductions in fibrosis. This study tested the hypothesis that, despite normalization of hemodynamic overload by LVAD, fibrosis and fibroblast activation persist resulting in sustained increases in myocardial stiffness. Methods and Results: Tissues from subjects with heart failure with reduced ejection fraction undergoing LVAD implantation (pre‐LVAD), from transplanted hearts with LVAD (post‐LVAD) or without cardiac pathology (control) were collected. Quantification of myocardial stiffness and collagen content revealed significant increases in pre‐LVAD versus control that remained elevated in post‐LVAD. Myocardial fibroblast populations increased in pre‐ and post‐LVAD hearts versus control. Control, pre‐LVAD, and post‐LVAD fibroblasts were isolated and plated on substrates with mechanical stiffnesses reflective of normal (≈2 kPa) or fibrotic (≈8 kPa) myocardium. Quantification of collagen I and α‐smooth muscle actin production demonstrated that control fibroblasts were responsive to substrate stiffness, whereas pre‐ and post‐LVAD fibroblasts were unresponsive and exhibited no significant differences on either substrate. Bulk‐RNA sequence analysis revealed changes in gene expression in pre‐LVAD versus control fibroblasts including mechano‐sensitive pathways that appear to be uncoupled, resulting in increased expression of genes implicated in proliferation, whereas mechano‐sensing genes were decreased. Conclusions: These data support that sustained cardiac hemodynamic overload leads to a phenotypic conversion in fibroblasts in which the capacity to detect changes in mechanical input is muted, thus contributing to retention of collagen content and stiffness in both pre‐ and post‐LVAD hearts.
- 15 April 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (8) , e039747
Open AccessPersistent Fibrosis in Heart Failure With a Reduced Ejection Fraction Linked to Phenotypic Differences in Human Cardiac Fibroblast Populations
Background: Myocardial fibrosis is prevalent in cardiomyopathies that result in heart failure with reduced ejection fraction. Heart failure with reduced ejection fraction treated with a left ventricular assist device (LVAD) yields hemodynamic unloading and may provide partial cardiomyocyte recovery, but contemporary studies reveal no consistent reductions in fibrosis. This study tested the hypothesis that, despite normalization of hemodynamic overload by LVAD, fibrosis and fibroblast activation persist resulting in sustained increases in myocardial stiffness. Methods and Results: Tissues from subjects with heart failure with reduced ejection fraction undergoing LVAD implantation (pre‐LVAD), from transplanted hearts with LVAD (post‐LVAD) or without cardiac pathology (control) were collected. Quantification of myocardial stiffness and collagen content revealed significant increases in pre‐LVAD versus control that remained elevated in post‐LVAD. Myocardial fibroblast populations increased in pre‐ and post‐LVAD hearts versus control. Control, pre‐LVAD, and post‐LVAD fibroblasts were isolated and plated on substrates with mechanical stiffnesses reflective of normal (≈2 kPa) or fibrotic (≈8 kPa) myocardium. Quantification of collagen I and α‐smooth muscle actin production demonstrated that control fibroblasts were responsive to substrate stiffness, whereas pre‐ and post‐LVAD fibroblasts were unresponsive and exhibited no significant differences on either substrate. Bulk‐RNA sequence analysis revealed changes in gene expression in pre‐LVAD versus control fibroblasts including mechano‐sensitive pathways that appear to be uncoupled, resulting in increased expression of genes implicated in proliferation, whereas mechano‐sensing genes were decreased. Conclusions: These data support that sustained cardiac hemodynamic overload leads to a phenotypic conversion in fibroblasts in which the capacity to detect changes in mechanical input is muted, thus contributing to retention of collagen content and stiffness in both pre‐ and post‐LVAD hearts.
- 4 August 2023
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 133 (Suppl_1)
Abstract P2111: Characterizing Human Cardiac Fibroblast Responsiveness To Hemodynamic Unloading In Heart Failure With Reduced Ejection Fraction
- 4 August 2023
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 133 (Suppl_1)
Abstract P2111: Characterizing Human Cardiac Fibroblast Responsiveness To Hemodynamic Unloading In Heart Failure With Reduced Ejection Fraction
- 11 December 2021
- Published by Elsevier in The American Journal of Cardiology
- Vol. 165, 58-64
Beta-Blocker Use in Hypertension and Heart Failure (A Secondary Analysis of the Systolic Blood Pressure Intervention Trial)
- 11 December 2021
- Published by Elsevier in The American Journal of Cardiology
- Vol. 165, 58-64
Beta-Blocker Use in Hypertension and Heart Failure (A Secondary Analysis of the Systolic Blood Pressure Intervention Trial)
- 1 September 2021
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 14 (9) , e008554
Pharmacologic Weight Loss for Heart Failure With Preserved Ejection Fraction
- 1 September 2021
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 14 (9) , e008554
Pharmacologic Weight Loss for Heart Failure With Preserved Ejection Fraction
- Open Access
- 1 December 2020
- Published by Elsevier in Heart Rhythm O2
- Vol. 1 (5) , 390-393
An approach towards individualized lower rate settings for pacemakers
- 1 December 2020
- Published by Elsevier in Heart Rhythm O2
- Vol. 1 (5) , 390-393
Open AccessAn approach towards individualized lower rate settings for pacemakers
- Open Access
- 1 September 2020
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 9 (17)
Heart Rate–Induced Myocardial Ca 2+ Retention and Left Ventricular Volume Loss in Patients With Heart Failure With Preserved Ejection Fraction
Background: Increases in heart rate are thought to result in incomplete left ventricular (LV) relaxation and elevated filling pressures in patients with heart failure with preserved ejection fraction (HFpEF). Experimental studies in isolated human myocardium have suggested that incomplete relaxation is a result of cellular Ca 2+ overload caused by increased myocardial Na + levels. We tested these heart rate paradigms in patients with HFpEF and referent controls without hypertension. Methods and Results: In 22 fully sedated and instrumented patients (12 controls and 10 patients with HFpEF) in sinus rhythm with a preserved ejection fraction (≥50%) we assessed left‐sided filling pressures and volumes in sinus rhythm and with atrial pacing (95 beats per minute and 125 beats per minute) before atrial fibrillation ablation. Coronary sinus blood samples and flow measurements were also obtained. Seven women and 15 men were studied (aged 59±10 years, ejection fraction 61%±4%). Patients with HFpEF had a history of hypertension, dyspnea on exertion, concentric LV remodeling and a dilated left atrium, whereas controls did not. Pacing at 125 beats per minute lowered the mean LV end‐diastolic pressure in both groups (controls −4.3±4.1 mm Hg versus patients with HFpEF −8.5±6.0 mm Hg, P =0.08). Pacing also reduced LV end‐diastolic volumes. The volume loss was about twice as much in the HFpEF group (controls −15%±14% versus patients with HFpEF −32%±11%, P =0.009). Coronary venous [Ca 2+ ] increased after pacing at 125 beats per minute in patients with HFpEF but not in controls. [Na + ] did not change. Conclusions: Higher resting heart rates are associated with lower filling pressures in patients with and without HFpEF. Incomplete relaxation and LV filling at high heart rates lead to a reduction in LV volumes that is more pronounced in patients with HFpEF and may be associated with myocardial Ca 2+ retention.
- 1 September 2020
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 9 (17)
Open AccessHeart Rate–Induced Myocardial Ca 2+ Retention and Left Ventricular Volume Loss in Patients With Heart Failure With Preserved Ejection Fraction
Background: Increases in heart rate are thought to result in incomplete left ventricular (LV) relaxation and elevated filling pressures in patients with heart failure with preserved ejection fraction (HFpEF). Experimental studies in isolated human myocardium have suggested that incomplete relaxation is a result of cellular Ca 2+ overload caused by increased myocardial Na + levels. We tested these heart rate paradigms in patients with HFpEF and referent controls without hypertension. Methods and Results: In 22 fully sedated and instrumented patients (12 controls and 10 patients with HFpEF) in sinus rhythm with a preserved ejection fraction (≥50%) we assessed left‐sided filling pressures and volumes in sinus rhythm and with atrial pacing (95 beats per minute and 125 beats per minute) before atrial fibrillation ablation. Coronary sinus blood samples and flow measurements were also obtained. Seven women and 15 men were studied (aged 59±10 years, ejection fraction 61%±4%). Patients with HFpEF had a history of hypertension, dyspnea on exertion, concentric LV remodeling and a dilated left atrium, whereas controls did not. Pacing at 125 beats per minute lowered the mean LV end‐diastolic pressure in both groups (controls −4.3±4.1 mm Hg versus patients with HFpEF −8.5±6.0 mm Hg, P =0.08). Pacing also reduced LV end‐diastolic volumes. The volume loss was about twice as much in the HFpEF group (controls −15%±14% versus patients with HFpEF −32%±11%, P =0.009). Coronary venous [Ca 2+ ] increased after pacing at 125 beats per minute in patients with HFpEF but not in controls. [Na + ] did not change. Conclusions: Higher resting heart rates are associated with lower filling pressures in patients with and without HFpEF. Incomplete relaxation and LV filling at high heart rates lead to a reduction in LV volumes that is more pronounced in patients with HFpEF and may be associated with myocardial Ca 2+ retention.